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Abstract
Background: The capacity to form romantic relationships and sexual health of adolescents in the Netherlands are
compromised by several factors, including young age of first intercourse and adolescent depression. Several thresholds
like own expenses, trust and embarrassment prevent adolescents to seek help for their sexual problems. To overcome
these thresholds, brief sex counselling has been developed. It has been used since 2006 within the Rotterdam-Rijnmond
Public Health Service, but there is lack of information about the (cost-) effectiveness. In the current study we will evaluate
the (cost-) effectiveness of brief sex counselling for sexual problems in adolescents and young adults between 18 and 25
years of age.
Methods: In a randomised controlled trial we will compare (1) brief sex counselling with (2) intensive sexological
treatment, and (3) delayed treatment (waiting list). Embedded in this RCT will be a trial-based economic evaluation,
looking at the cost-effectiveness and cost-utility of brief sex counselling versus the two other interventions. Four hundred
fifty adolescents (aged 18-25) with sexual problems will be recruited among the persons who visit the Public Health
Service (PHS) and through various websites. After a screening procedure, eligible participants will be randomly allocated
to one of the three intervention groups. Primary outcome measure of the clinical evaluation is the severity of sexual
problems. Other outcomes include psychological distress, especially depression. The economic evaluation will be
performed from a societal perspective. Costs will be assessed continuously by a retrospective questionnaire covering
the last 3 month. All outcome assessments (including those for the economic evaluation) will take place via the internet
at baseline, and at 3, 6, 9, and 12 months after baseline.
Discussion: The proposed research project will be the first study to provide preliminary data about the effect and cost-
effectiveness of brief sex counselling in youth in comparison with intensive sexological treatment and delayed treatment.
It is anticipated that positive results in (cost-) effectiveness of the proposed intervention will contribute to the
improvement of sexual health care for adolescents and young adults.
Trial registration: The study has been registered at the Netherlands Trial Register, part of the Dutch Cochrane Centre
(NTR1952)
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Background
Sexual health of adolescents has gained more attention
over the last years [1,2]. Sexual health is described by the
World Health Organisation (WHO) as:
"... a state of physical, emotional, mental and social well-
being in relation to sexuality; it is not merely the absence
of disease, dysfunction or infirmity. Sexual health requires
a positive and respectful approach to sexuality and sexual
relationships, as well as the possibility of having pleasur-
able and safe sexual experiences, free of coercion, discrim-
ination and violence. For sexual health to be attained and
maintained, the sexual rights of all persons must be
respected, protected and fulfilled [3]".
The past decade has also seen a growing recognition of the
existence of romantic relationships, experiences and sex-
ual activities in adolescents [4]. With this attention some
developments have taken place that could compromise
the sexual health and romantic relationship capacities of
adolescents.
The first development is the increasing proportion of
young people that have sexual intercourse before the age
of 16 [5]. Sexual intercourse before this age is associated
with increased risks [6]. Men and women who had their
first sexual encounter before the age of 16 show increased
regret of this experience [5,7,8]. For both, boys and girls,
the early onset of intercourse was associated with the
experienced pressure by peers, and in girls this was also
associated with the lack of control in the process of and
during sexual intercourse [5]. Another study found
increased rates of coercion to have sex in women who had
their first sexual intercourse at a younger age. It is also
found that the incidence of sexually transmitted diseases
(STD's) was higher for the group who had their first sexual
intercourse before the age of 16 [6,7]. Girls who began
sexual activity before the age of 13 were twice as likely to
become infected with an STD as girls who started sexual
activity after the age of 21. Other associations of early sex-
ual activity were a greater likelihood of becoming a single
mother, more abortions, and lower levels of personal hap-
piness [6].
Furthermore the younger a person was at his/her first sex-
ual intercourse the higher the likelihood was of having
multiple sex partners (at least five sex partners lifetime or
four sex partners during the last six months). Having mul-
tiple sex partners is associated with (sexual) risk behav-
iours such as unsafe sex (not using contraceptives),
smoking, drug- and alcohol use [8-11].
As mentioned before, unsafe sex is a common risk factor
among adolescents and young adults. It has been found
that only in the US, in 19 million new STD cases that
occur every year, half of these are in individuals between
15 and 24 years of age [12]. Pregnancy is of course another
consequence of unsafe sex. Darroch, Frost and Singh
(2001) found that the US has the highest pregnancy and
birth rate in women between 15 and 19 years compared
to other developed countries. These higher rates arise pri-
marily because of less, and probably less effective contra-
ceptive use [13].
It is well known that mood disorders, and especially
major depressive disorder, are among the most common
mental disorders in adolescence [14-16]. Mental disor-
ders, including depression, play a role in the development
of sexual risk behaviour and sexual health problems
[17,18]. Sex- and drugs-related behaviour predicts an
increased likelihood of depression. Among girls, both
experimental behaviour patterns (experimenting with sex,
drugs and alcohol) and high-risk behaviour patterns
(excessive drinking and/or drug use, and unprotected sex-
ual contact) were found to increase the odds of subse-
quent depression. Among boys only high-risk behaviour
patterns increased the odds of the development of subse-
quent depression [19].
Romantic attractions, activities (dating, kissing, more
than kissing (like touching each other), etcetera) and rela-
tionships were also associated with a greater risk of
depressive symptoms in adolescence [4,20]. Adolescents
who had romantic relationships and who engaged in
romantic activities, compared with adolescents who had
not, reported increased depressive symptoms over time
[21]. Several models have been proposed to explain this
association. For example, the attention impairment
model [22], suggests that romantic activities takes atten-
tion away from other important areas of functioning and
so causing impairment, which increases the risk for
depressive symptoms. Impairment of romantic function-
ing (interpersonal skills in the romantic domain)
impaired by depressive symptoms can furthermore have
far reaching consequences for the relational development
of adolescents [4].
Another study in 7th-12th grade students, age 13 to 18,
found that depressive symptoms were associated with
increased sexual risk. Among boys depressive symptoms
were associated with non condom use at last sexual inter-
course, among both boys and girls it was associated with
a history of STD [17,23]. Thus, the relationship in adoles-
cents and young adults between sexual behaviour and sex-
ual risk behaviour on the one hand, and
psychopathology, particularly depression, on the other
hand, appears to be bidirectional.
In the Netherlands, adolescents are - in general - sexually
healthy but there are some alarming developments.BMC Public Health 2009, 9:459 http://www.biomedcentral.com/1471-2458/9/459
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Bakker, et al. (2009) examined the sexual health of 6428
men and women between 15 and 70 years old (girls 15-18
years old N = 443; boys 15-18 years old N = 368). Of the
15 and 16 year olds, 33% of the girls and 25% of the boys
had sexual intercourse. At the age of 17-18 these percent-
ages have almost doubled. Girls with a lower education
level have significantly more sexual experience than
higher educated girls. Of the 15 to 18 year olds, 3.8% of
the boys, and 2.9% of the girls have had more than 10 sex-
ual partners up to that point of their lives. Furthermore,
32.6% of these boys and 28.5% of these girls experienced
feelings of guilt about their sexual behaviour. Pregnancy
and birth control were also examined in this study.
Among boys, 1.1% of their female sexual partners had
been pregnant and 0.4% had the baby. More of the part-
ners of high-educated men under 26 years of age who
experienced unwanted pregnancy had abortions than low
educated men, but the partners of the latter more often
gave childbirth. Among girls, 3.7% had been pregnant
and 0.8% had the baby. Low educated girls under 26 years
of age had more (unexpected) pregnancies, children, and
abortions than high educated girls. Among boys, 58.9%
uses no contraceptives, while this is the case for 40.9% of
the girls. Sexual victimization is more common among
girls than among boys (20.2% vs. 2.3%) [24]. Compara-
ble results have been found in other studies in the Neth-
erlands [1,25].
To improve this situation the Dutch national government
has created a new service that facilitates assistance in the
area of young peoples' sexual health. The core is a nation-
wide network of sexual health service provision centres
(called 'Sense') for young people up to 25 years of age
with questions concerning or problems with sexual
health. The regulation builds on the experiences of the
pilot version of Sense (pilot from 2005-2008), which was
situated in three areas. One of them being the southern
South-Holland (sSH) region. In the pilot version of Sense
sSH, the Rotterdam-Rijnmond Public Health Service
(PHS) identified an omission. Referral of adolescents with
sexual health problems could not be performed ade-
quately; the threshold for referral is too high (for example
too expensive, too far away, etcetera). Research has shown
that not everyone who needed help or advice for sexual
health issues actually sought or had access to that help.
The unfamiliarity with the available resources is one fac-
tor. Furthermore, the lack of trust in the available help, the
costs, and reluctance of the help-seeking person are factors
that play a role [24]. This implies that a large group of
young people who need help for sexual issues have no
access to the necessary care. For this reason the Rotterdam-
Rijnmond PHS has, in addition to Sense, appointed a sex
counsellor who helps to address the sexual problem in a
maximum of three, free of charge and anonymous consul-
tations of 45 minutes maximum. This service is called
brief sex counselling. Its aim is to provide tailored and
practical advice and/or reference to specialised health
care, and to bridge the gap between Sense and this, more
intensive, specialized help.
The earlier mentioned developments [24] regarding sex-
ual health and the related mental health problems [17,18]
form a major problem for youth in the Netherlands. Brief
sex counselling might be a solution as it aims to treat the
sexual problems of these adolescents in an early stage.
Related mental disorders (like depression) would be less
likely to develop or escalate. It is expected that brief sex
counselling will prevent more serious and chronic prob-
lems in the future. However, there is no scientific evidence
yet.
Goldmeier and colleagues calculated that, in 2004, the
average costs of the treatment of sexual dysfunctions in
the UK for women were €417 when delivered by a psy-
chologist and €896 when delivered by a sex therapist [26].
Potentially, a certain proportion of patients with sexual
problems do not require this type of intensive and costly
treatment, but can adequately and satisfactorily be treated
with less intensive and lower-cost alternatives. For
instance, in the Netherlands it was estimated that 14%
(respectively 56,000 of the extrapolated total of 400,547)
of the patients treated in hospital outpatient clinics for
sexology and 24% (respectively 80,500 of the extrapo-
lated total of 335,594) of the patients treated in mental
health care centres, could be adequately treated with a
cheaper, low-threshold intervention [25,27]. It can be
expected that brief sex counselling is a cheaper and more
approachable option to treat sexual problems in adoles-
cents than standard sexual health care provided in com-
munity mental health services or hospital outpatient
clinics for sexology.
There are two main reasons to conduct this study that are
related to current policy aims to improve the sexual health
in youth. First, it can be assumed that brief sex counselling
for high risk groups has a preventive impact on the recur-
rence of their sexual condition. This would reduce, more-
over, the patient flow to more expensive health care in
hospitals and mental health care institutions [25]. Sec-
ond, a secondary prevention effect of sex counselling on
mental health problems, in particular depression, is pre-
dicted [25,28].
The objectives of the current study are threefold. The first
is the development of protocols for brief sex counselling
in the field of sexual health to address problems in sexual
functioning in youth. Furthermore a training plan will be
developed to train nurses and public health workers to
implement these protocols for brief sex counselling. The
second objective is to investigate the effects of brief sexBMC Public Health 2009, 9:459 http://www.biomedcentral.com/1471-2458/9/459
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counselling on somatic, mental and sexual health. The
third and last aim is to investigate the cost-effectiveness of
brief sex counselling. We will examine whether brief sex
counselling is preferable to more intensive formats of sex-
ual health care and delayed treatment in terms of costs,
impact and utilities from a social perspective.
Methods
Design
The proposed study is a prospective, randomised control-
led trial (RCT). The subjects will be randomized to one of
the three conditions: (1) brief sex counselling, (2) inten-
sive sexological treatment, and (3) a delayed treatment
(waiting list). The trial flow of the proposed subject enrol-
ment and randomization procedures are graphically
shown in Figure 1. This study has been approved by the
ethics committee academic hospital Maastricht/Maas-
tricht University, the Netherlands. Embedded in this RCT
will be a trial-based economic evaluation to investigate
the cost-effectiveness and cost-utility of brief sex counsel-
ling versus intensive sexological treatment (see Figure 1).
Participants
The patient population we aim to investigate consists of
adolescents with sexual problems. Patients are eligible to
participate if they meet the following criteria: age between
18 and 25 years old; at least mild to moderate sexual prob-
lems (based on Questionnaire for the Screening of Sexual
Dysfunction [29,30], International Index of Erectile Func-
tion (men) [31] and Female Sexual Functioning Index
(female) [32]); no severe psychiatric co-morbidity or rela-
tional problems, and the sexual problems are not caused
by disease, medication use or physical disabilities.
Interventions
Brief sex counselling
Brief sex counselling is a brief, free of charge and easily
accessible treatment for sexual problems of people
between 18 and 25 years of age. In a maximum of three
sessions, of 45 minutes each, a sex counsellor attempts to
solve the problems or refers to more specialized help. The
treatment is aimed at people without relationship and/or
psychiatric problems. The sessions include providing
information, psycho-education and limited advice on
behaviour change. Furthermore home exercise assign-
ments can be given, and the experiences with these exer-
cises are discussed. The possibility for adolescents to talk
about their sexuality in a non-threatening environment
could initiate the problem-solving process.
Intensive sexological treatment
In a maximum of 10 treatment sessions a (Dutch Associa-
tion for Sexology) certified sexologist offers an intensive
form of treatment for the sexual problem(s) of the partic-
ipant. This is the standard format of care for adults with
sexual problems. In contrast to brief sex counselling,
intensive sexological treatment also addresses the rela-
tional and/or personal psychological problems which
possibly underlie the base of the sexual problems. The
treatment is largely based on cognitive-behavioural ther-
apy. In many cases homework assignments have to be car-
ried out. The participant is taught to recognize and change
thoughts which could play a negative role in their sex life.
Delayed treatment
In the event of the participant being randomized into the
waiting list, a period of 26 weeks follows in which no
treatment is offered. Participants are requested not to
engage in other types of professional treatment. At the end
of the waiting list period the participant can choose
between brief sex counselling and the intensive sexologi-
cal treatment.
Protocol
The protocol that has been developed for the brief sex
counselling sessions is based on the principles and prac-
tice of sex counselling in general and on a guideline that
was developed for the Sense sessions [33,34]. The proto-
col chapters address problems of sexual desire, sexual
arousal, orgasm and sexual pain. First, a description of the
disorder is given. Next, specific questions are provided for
sexual history taking. Furthermore an action plan is pro-
vided. Most of the time is spent on the action plan. This
describes what has to be or can be done to solve the prob-
lem. The first step in the plan is providing information.
This is done to improve the client's knowledge about the
cause of his or her problem and the factors that maintain
it. A second action point concerns cognitive and behav-
ioural aspects. Several compromised cognitive processes
and deficient coping strategies can underlie the sexual
problems. During the sessions an attempt is made to iden-
tify, change and adjusted these processes and strategies.
The protocol provides examples of these processes and
strategies and how to deal with them. The last action point
concerns teaching of sensate-focus exercises. These exer-
cises aim to help a person or couple to (re)discover sexual
needs and preferences. Different exercises provided are
tailored to address different sexual problems.
Research Questions
Both for the effectiveness study as well as for the economic
evaluation study we have defined a number of research
questions:
Effectiveness study
1. Does brief sex counseling as envisaged, when compared
to delayed treatment, improve the sexual and general
mental health of adolescents and young adults? To which
extent (effect size) and in what respect (which outcome
dimensions)?BMC Public Health 2009, 9:459 http://www.biomedcentral.com/1471-2458/9/459
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2. Is brief sex counseling efficacious, when compared to
delayed treatment, in preventing escalation of (sexual and
mental) health problems compared with no help?
Economic evaluation
1. Is, from a social perspective, the delivery of brief sex
counselling compared to intensive sexological treatment,
preferable in terms of costs, effects and utilities?
a. What are the (extra) costs of the delivery of brief sex
counselling compared to intensive sexological treat-
ment and waiting list group?
b. What are the (extra) effects (measured in health sta-
tus and quality of life) of brief sex counselling com-
pared to intensive sexological treatment and waiting
list group?
Outcome measures
Several instruments will be used to assess the effects of
brief sex counselling on sexual functioning, depression
and other psychological and physical complaints, and on
secondary outcomes. Furthermore instruments will be
used to assess the cost-effectiveness of brief sex counsel-
ling from a social perspective. The outcomes will be meas-
ured before randomization (during initial screening), at
baseline and at 3, 6, 9 and 12 months after baseline (Addi-
tional file 1).
Sexual functioning
Questionnaire for the Screening of Sexual Dysfunctions
The Questionnaire for the Screening of Sexual Dysfunc-
tions (QSSD) [29,30] is a self-report instrument with 70
items, each assessed using a 5-point or a 7-point Likert-
scale, which aims to measure the presence (and level) of
sexual difficulties. This instrument has different versions,
dependent on gender, partnered status and gender of the
partner. Anchor points used are 'almost never' and
'always' for frequency and 'no trouble' and 'very much
trouble' for associated distress.
Female Sexual Functional Index
The Female Sexual Functional Index (FSFI) [32] is a mul-
tidimensional self-report instrument with 19 items, with
responses assessed using a 6-point Likert-scale, which
aims to measure sexual functioning on the dimensions of
sexual desire, arousal, lubrication, orgasm, satisfaction
and pain. High score indicates healthy sexual functioning.
Its sound psychometric properties have been proven [35].
International Index of Erectile Function
The International Index of Erectile Function (IIEF) [31] is
a multidimensional self-report instrument with 15 items,
assessed using a 6-point Likert-scale, meant to measure
male sexual functioning on the dimensions of erectile
functioning, orgasmic functioning, sexual desire, inter-
course satisfaction and overall satisfaction. A high score
indicates healthy erectile functioning. Its sound psycho-
metric properties have been proven [31].
Depression and psychological/physical complaints
Center for Epidemiologic Studies Depression Scale
The Center for Epidemiologic Studies Depression Scale
(CES-D) [36] is a self-report instrument with 20 items,
assessed using a 4-point Likert-scale, meant to measure
depressive symptoms on the dimensions somatic-
retarded activity, depressed affect, positive affect and
interpersonal affect. People with a score of 16 and higher
can be identified as "possible cases". Several studies have
demonstrated sound psychometric properties [36,37].
Brief Symptom Inventory
The Brief Symptom Inventory (BSI) [38] is a self-report
instrument to measure psychological distress, with 53
items assessed using a 5-point Likert-scale. The dimen-
sions measured are the same as its predecessor the Symp-
tom Checklist-90. The total score of the BSI can be used as
an index of severity for general psychological distress
(score range 0-212). Several studies have demonstrated
sound psychometric properties [39,40].
Trial flow proposed participants enrolment and randomiza- tion procedures Figure 1
Trial flow proposed participants enrolment and rand-
omization procedures. PHS*: Public Health Service, GP**: 
General Practitioner.
After waiting period
enrolment in one of the two
treatment options
6 month follow-up for primary endpoints
R ecruitment population (adolescents (18-
25)  who  visit  PHS*,  GP**  or  various
websites)
Excluded:
-P r o m i n e n t  A x i s  I / I I  c o -
morbidity
- Severe relation problems
- Sexual problems are due
to disease, medication
and/or physical problems
E ligible subjects;
N=450
Randomize
Brief sex
counselling(3
sessions); N=150
Intensive sexological
treatment (10 sessions);
N=150
Waiting list period(12
weeks); N=150BMC Public Health 2009, 9:459 http://www.biomedcentral.com/1471-2458/9/459
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Medical Outcomes Study 36-item Short Form Health Survey
The Medical Outcomes Study 36-item Short Form Health
Survey (SF-36) [41] is a self-report instrument with 36
items, assessed using a 5-point Likert-scale, meant to
measure the quality of life. Eight dimensions can be iden-
tified: physical functioning, role disabilities caused by
physical health problems, pain, general health percep-
tion, vitality, social functioning, role disabilities caused by
emotional problems, and mental health. These eight
dimensions can be summed in a physical and a psycho-
logical dimension score. Several studies have demon-
strated sound psychometric properties [42,43]. Within the
cost-utility analysis, utilities will be derived. The term util-
ity refers to the preferences individuals or society may
have for any particular set of health outcomes [44]. The
patient's health status will be measured with the SF-36;
the Short Form 6D will be used to calculate utilities that
incorporate preferences from a general population sample
Assessment of DSM-IV Personality Disorders questionnaire
The Assessment of DSM-IV Personality Disorders ques-
tionnaire (ADP-IV) [45] is a self-report instrument with
94 items, assessed using a 7-point Likert-scale, meant for
a categorical and dimensional measurement of the DSM-
IV personality disorders. Several studies have demon-
strated sound psychometric properties [46].
Economic evaluation
The economic evaluation will be performed from the soci-
etal perspective. At the cost side we distinguish three cost-
categories: health care sector costs, costs for the patient
and family, and productivity costs. For this study we will
develop a cost questionnaire especially designed for this
group, based on existing questionnaires [25,47], which
will identify all relevant cost aspects. To measure the
actual use of resources data will be obtained using com-
bined sources (registrations by professionals and cost
questionnaire). For the measurement of production
losses, the patient modules of the PROductivity and DIS-
ease Questionnaire (PRODISQ) will be used [47-49]. Pro-
ductivity costs will be calculated by means of the friction
cost method, based on a mean added value of the Dutch
working population. This method takes into account pro-
duction losses confined to the period needed to replace a
sick employee [49].
Secondary outcomes
Credibility/Expectancy Questionnaire
The Credibility/Expectancy Questionnaire (CEQ) [50] is a
multidimensional self-report instrument with 16 items,
using on a 9- or 10-point Likert-scale, meant to measure
the expectancy and credibility a person has about the ther-
apy received. Its sound psychometric properties have been
proven [51].
Self-Esteem and Relationship Questionnaire
The Self-Esteem and Relationship Questionnaire (SEAR)
[52] is a self-report instrument with 14 items, assessed
using a 5-point Likert-scale, meant to measure sexual rela-
tionship and psychosocial factors specific for people with
sexual problems. Two domains can be distinguished; sex-
ual relationships and confidence. High scores indicate
problems with regards to the participant's sexual relation-
ship and confidence. Its sound psychometric properties
have been proven [52].
Treatment Satisfaction Questionnaire
The Treatment Satisfaction Questionnaire (TSQ) is a new
instrument, derived from the Erectile Dysfunction inven-
tory of Treatment Satisfaction (EDITS), and adjusted so it
would fit the total study population [53]. This instrument
measures the satisfaction of the participants with the treat-
ment as a whole and the different aspects of the treatment.
The reliability and validity of de EDITS were well estab-
lished.
Demographic and Biographic Questionnaires
Demographic and biographic questionnaires will be used
to assess general information like gender, place of birth,
age, occupation, but also the use of medication, drugs
and/or alcohol, as well as medical and psychological
problems.
Sample size
In a repeated-measures analysis of the within-between-
interaction effect, a sample size of 95 in each group has a
power of 95% to detect an effect size of 0.41 using
repeated-measures MANOVA with a 0.050 two-sided level
of significance. In the absence of published controlled
studies on professional care for young people with sexual
problems, we set the desired effect size at d = 0.40, repre-
senting the central point of the range of effect sizes that are
considered as 'medium size' [54]. N = 150 per condition
is deemed necessary to guarantee the required number of
respondents, in view of the expected non-response after
inclusion and later attrition [55]. In a repeated-measures
analysis of the within-subjects effect, a sample size of 86
in the treated group has a power of 95% to detect an effect
size of 0.25 using a repeated-measures MANOVA with a
0.050 two-sided level of significance. The before men-
tioned N = 150 per condition is expected to guarantee the
required number of participants.
Randomisation and procedure
For this study a block randomisation procedure will be
used to ascertain that each intervention runs in equally
large groups. Although the order of the interventions var-
ies randomly within each block, a person running the trial
could deduce some of the next treatment allocations ifBMC Public Health 2009, 9:459 http://www.biomedcentral.com/1471-2458/9/459
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they discovered the block size. In this study we use larger
block sizes (30) and randomly vary in block size which
can ameliorate this problem [55]. Allocation will be per-
formed by a central independent research assistant after
getting informed consent, screening, and checking the in-
and exclusion criteria, using Schouten's (1995) adaptive
biased urn randomization for small strata. This keeps ran-
domization unpredictable up to and including the last
participant on each site, while keeping the group sizes at
each site in good balance [56].
The questionnaires will be administered using a compu-
ter. All assessments will take place at home via internet.
Preceding an upcoming assessment point, participants
will receive an email (one week before the end of the treat-
ment and 3 months after the start of the follow-up meas-
urement). If a participant fails to complete the assessment
within one week, an email-reminder will be sent. When
the participant fails to fill in the questionnaires, a phone
call will be made.
Recruitment
Participants will be recruited through different routes;
referrals from Rotterdam-Rijnmond PHS, southern South-
Holland PHS, Hollands-middle PHS, Maastricht/Heerlen
PHS, Sense, and various websites. Adolescents who visit
the PHS for a STI or Sense consult, and who report sexual
problems, will be asked if they are interested in participat-
ing in the study. Adolescents who visit websites providing
sexual information, like http://www.sense.info, can click
on a banner if they are interested to participate. After thus
reporting their interest, they receive an email containing
information about the study protocol, and an informed
consent (IC) form. Adolescents who return their signed IC
form receive login codes for the questionnaires on the
internet. Participants who score above the cut-off score on
the QSSD and IIEF/FSFI, and meet the inclusion criteria
are included in the study. Participants who do not meet
the inclusion criteria are offered suitable alternative treat-
ment options.
Analyses
Clinical analyses
Our primary (base-case) analyses will be performed
according to the intention-to-treat principle, including
data from all participants regardless of whether they
received the intervention or not. For the analyses we will
use SPSS statistical software and Excel (for the boot-
straps). Respondents for whom at least 75% of the data
per measurement instrument are available will be
included in the analysis. Missing data on item level will be
handled using SPSS missing value analysis. Completely
missing measurements will be handled using multiple
imputation. Analysis will include comparisons of the
intervention groups (brief sex counselling, sexological
treatment and waiting list) as well as more complicated
multi-level analysis. The accuracy of the findings will be
expressed in terms of 95% confidence intervals.
To test the main research questions, difference scores for
all outcome variables will be calculated and compared
between the three intervention groups using MANOVA. In
the case of significant multivariate results, subsequent
univariate analysis using independent groups t-tests will
be conducted to assess the significance of differences pre/
post intervention between control and experimental
groups.
Economic evaluation
A baseline analysis will be performed to examine the com-
parability of groups at baseline for both costs and out-
comes. If necessary methods will be applied to control for
differences in baseline [57]. To investigate whether data
are normally distributed a Kolmogorov-Smirnov test will
be performed. Despite the usual skewness in the distribu-
tion of costs, the arithmetic means will be generally con-
sidered the most appropriate measures to describe cost
data [58,59]. Therefore arithmetic means (and standard
deviations) will be presented. In case of skewness of the
cost data, non-parametric bootstrapping will be used to
test for statistical differences in costs between the inter-
vention and control group. The bootstrap replications will
be used to calculate 95% confidence intervals around the
costs (95% CI), based on the 2.5th and 97.5th percentiles.
If cost data are distributed normally, t-tests will be used.
The incremental cost-effectiveness ratio (ICER) will be
determined on the basis of incremental costs and effects
of sex counselling compared to sexological treatment and
a waiting-list group. The cost-effectiveness ratio will be
stated in terms of costs per outcome rate (increase in sex-
ual functioning, decrease of depressive symptoms) the
cost-utility ratio will focus on the net cost per utility
gained.
The robustness of the ICER will be checked by non-para-
metric bootstrapping. Bootstrap simulations will also be
conducted in order to quantify the uncertainty around the
ICER, yielding information about the joint distribution of
cost and effect differences. The bootstrapped cost-effec-
tiveness ratios will be subsequently plotted in a cost-effec-
tiveness plane. The choice of treatment depends on the
maximum amount of money that society is prepared to
pay for a gain in effectiveness, which is called the ceiling
ratio. Therefore, the bootstrapped ICERs will also be
depicted in a cost-effectiveness acceptability curve show-
ing the probability that sex counselling is cost-effective
using a range of ceiling ratios. Additionally, to demon-
strate the robustness of our base-case findings, multi-way
sensitivity analyses will be performed [60].BMC Public Health 2009, 9:459 http://www.biomedcentral.com/1471-2458/9/459
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Collaboration
The current study will be conducted in collaboration with
several disciplines. The Rotterdam-Rijnmond PHS will be
involved in the development and implementation of brief
sex counselling. PsyQ Rotterdam (specialized mental
health institute) will be involved in the development and
implementation of the intensive sexological treatment.
Furthermore, there is collaboration between the Dutch-
Flemish research school Experimental Psychopathology
(EPP) and the Care and Public Health Research Institute
(Caphri).
Discussion
There are some alarming developments regarding sexual
health in adolescents. To overcome the threshold in the
treatment of sexual problems, brief sex counselling has
been developed. It has been used successively since 2006,
but research evaluating this intervention is necessary.
Therefore, in the current study we will evaluate the (cost-
) effectiveness of brief sex counselling for sexual problems
of adolescents and young adults under the age of 25 years
of age. We shall compare brief sex counselling with an
intensive sexological treatment and a delayed treatment
condition.
Methodological considerations
Brief sex counselling is a relatively new intervention with
which the experience in practise is restricted. The interven-
tion is carried out in the - also relatively new - setting of
adjuvant sexuality consultations for young people. How-
ever, on the basis of the experiences between 2006 and
2008 (pilot version of Sense), the research group is con-
vinced that it is important to start with this intervention
because it may reveal sexual health problems that cannot
be solved within the regular setting. The threshold for reg-
ular sexological treatment might prove to be too high for
some groups, who may suffer severe health consequences
in later life. Furthermore, this is one of the first economic
evaluation studies and the SF-36 does not take into
account a sexual dimension. Finally, the questionnaires
are administered among a relative young population.
Conclusion
Brief sex counselling is a new treatment with interesting
possibilities. It might lower the threshold to seek profes-
sional help for sexual health problems, and could prevent
health consequences in later life. The current study con-
tributes to the growing literature on sexual health in ado-
lescents and young adults.
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